Simulating serial-target antibacterial drug synergies using flux balance analysis

Andrew S. Krueger, Christian Munck, Gautam Dantas, George M. Church, James Galagan, Joseph Lehár, Morten O.A. Sommer

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Flux balance analysis (FBA) is an increasingly useful approach for modeling the behavior of metabolic systems. However, standard FBA modeling of genetic knockouts cannot predict drug combination synergies observed between serial metabolic targets, even though such synergies give rise to some of the most widely used antibiotic treatments. Here we extend FBA modeling to simulate responses to chemical inhibitors at varying concentrations, by diverting enzymatic flux to a waste reaction. This flux diversion yields very similar qualitative predictions to prior methods for single target activity. However, we find very different predictions for combinations, where flux diversion, which mimics the kinetics of competitive metabolic inhibitors, can explain serial target synergies between metabolic enzyme inhibitors that we confirmed in Escherichia coli cultures. FBA flux diversion opens the possibility for more accurate genome-scale predictions of drug synergies, which can be used to suggest treatments for infections and other diseases.

Original languageEnglish
Article numbere0147651
JournalPloS one
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint Dive into the research topics of 'Simulating serial-target antibacterial drug synergies using flux balance analysis'. Together they form a unique fingerprint.

  • Cite this

    Krueger, A. S., Munck, C., Dantas, G., Church, G. M., Galagan, J., Lehár, J., & Sommer, M. O. A. (2016). Simulating serial-target antibacterial drug synergies using flux balance analysis. PloS one, 11(1), [e0147651]. https://doi.org/10.1371/journal.pone.0147651